Core Viewpoint - The company has announced its 2024 annual profit distribution plan, which includes a cash dividend of 1.2 yuan per 10 shares for all shareholders, based on a total share capital of 1,249,800,000 shares after excluding repurchased shares [2][6]. Group 1: Profit Distribution Plan - The total share capital of the company is 1,279,800,000 shares, with 30,000,000 shares in the repurchase account excluded, resulting in a base of 1,249,800,000 shares for the cash dividend distribution [2][6]. - The total cash dividend amount is calculated to be 149,976,000 yuan, which translates to a per-share cash dividend of approximately 0.1171870 yuan after considering the total share capital [10]. - The profit distribution plan was approved at the shareholders' meeting held on May 14, 2025, and the implementation of the plan will occur within two months of this approval [5][4]. Group 2: Dividend Payment Details - The record date for the dividend distribution is set for May 28, 2025, and the ex-dividend date is May 29, 2025 [7]. - The cash dividends will be directly credited to the accounts of shareholders through their respective securities companies on the ex-dividend date [9]. - The company will not withhold individual income tax for certain shareholders, with tax obligations determined based on the holding period of the shares [6]. Group 3: Shareholder Rights and Adjustments - Shares repurchased by the company will not participate in the profit distribution, losing rights to dividends and other benefits [6]. - The distribution method ensures that the total share capital remains unchanged post-distribution, although the per-share dividend will decrease due to the fixed total cash dividend amount [10]. - The company has provided contact information for inquiries regarding the dividend distribution process [8].
证券代码：002550 证券简称：千红制药 公告编号：2025-014